Position in HLN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$18,660
-$1,360 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#447
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $347,449 across 4 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (5.4% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,660 | 2,000 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $20,020 | 2,000 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $20,220 | 2,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $18,854 | 2,102 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $20,740 | 2,000 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $28,348 | 2,755 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $35,822 | 3,755 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $39,727 | 3,755 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $31,016 | 3,755 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $31,879 | 3,755 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $30,903 | 3,755 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $31,279 | 3,755 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $31,466 | 3,755 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $36,931 | 4,537 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $40,296 | 5,037 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $33,227 | 5,456 | Shares | Sole | 2022-11-09 | |
| No filing history on record for this holder in this stock. | ||||||